| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |